{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:49:48Z","timestamp":1779126588945,"version":"3.51.4"},"reference-count":206,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2018.4516","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T05:47:16Z","timestamp":1533534436000},"source":"Crossref","is-referenced-by-count":22,"title":["Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)"],"prefix":"10.3892","author":[{"given":"Alessia","family":"Finotti","sequence":"first","affiliation":[{"name":"Department of Life Sciences and Biotechnology, Ferrara University, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Allegretti","sequence":"additional","affiliation":[{"name":"Oncogenomics and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Gasparello","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Biotechnology, Ferrara University, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Giacomini","sequence":"additional","affiliation":[{"name":"Oncogenomics and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Crete, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Spoto","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Catania University, 95125 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gambari","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Biotechnology, Ferrara University, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"key20200713185112_b1-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/gm477","article-title":"Circulating tumor cells and DNA as liquid biopsies","volume":"5","author":"Heitzer","year":"2013","journal-title":"Genome Med"},{"key":"key20200713185112_b2-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"key20200713185112_b3-ijo-53-04-1395","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.18632\/oncotarget.23131","article-title":"The dawn of the liquid biopsy in the fight against cancer","volume":"9","author":"Dom\u00ednguez-Vigil","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185112_b4-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e87838","DOI":"10.1371\/journal.pone.0087838","article-title":"Direct quantification of cell-free, circulating DNA from unpurified plasma","volume":"9","author":"Breitbach","year":"2014","journal-title":"PloS One"},{"key":"key20200713185112_b5-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1373\/clinchem.2014.222679","article-title":"Circulating tumor DNA as a liquid biopsy for cancer","volume":"61","author":"Heitzer","year":"2015","journal-title":"Clin Chem"},{"key":"key20200713185112_b6-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/annonc\/mdx766","article-title":"Incorporating blood-based liquid biopsy information into cancer staging: Time for a TNMB system","volume":"29","author":"Yang","year":"2018","journal-title":"Ann Oncol"},{"key":"key20200713185112_b7-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm.3522","article-title":"Tumor heterogeneity confounds and illuminates: Assessing the implications","volume":"20","author":"Kleppe","year":"2014","journal-title":"Nat Med"},{"key":"key20200713185112_b8-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med"},{"key":"key20200713185112_b9-ijo-53-04-1395","first-page":"646","article-title":"Free DNA in the serum of cancer patients and the effect of therapy","volume":"37","author":"Leon","year":"1977","journal-title":"Cancer Res"},{"key":"key20200713185112_b10-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"24561","DOI":"10.18632\/oncotarget.25337","article-title":"Circulating tumor cells in clinical research and monitoring patients with colorectal cancer","volume":"9","author":"Burz","year":"2018","journal-title":"Oncotarget"},{"key":"key20200713185112_b11-ijo-53-04-1395","first-page":"4675","article-title":"Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients","volume":"61","author":"Sozzi","year":"2001","journal-title":"Cancer Res"},{"key":"key20200713185112_b12-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1158\/1078-0432.CCR-11-0564","article-title":"Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan","volume":"18","author":"Spindler","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20200713185112_b13-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e47020","DOI":"10.1371\/journal.pone.0047020","article-title":"Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers","volume":"7","author":"Perkins","year":"2012","journal-title":"PloS One"},{"key":"key20200713185112_b14-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/1078-0432.CCR-14-1190","article-title":"Circulating tumor cells and circulating tumor DNA: Challenges and opportunities on the path to clinical utility","volume":"21","author":"Ignatiadis","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key20200713185112_b15-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1758834010378414","article-title":"Circulating tumour cells: Their utility in cancer management and predicting outcomes","volume":"2","author":"Krebs","year":"2010","journal-title":"Ther Adv Med Oncol"},{"key":"key20200713185112_b16-ijo-53-04-1395","first-page":"295","article-title":"Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes","volume":"43","author":"Millner","year":"2013","journal-title":"Ann Clin Lab Sci"},{"key":"key20200713185112_b17-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41575-018-0015-8","article-title":"Personalized screening for colorectal cancer","volume":"15","author":"Kuipers","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20200713185112_b18-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"86253","DOI":"10.18632\/oncotarget.21134","article-title":"Liquid biopsy in colon cancer: Comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR","volume":"8","author":"Kloten","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185112_b19-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/cam4.1051","article-title":"The prognostic value of simultaneous tumor and serum RAS\/RAF mutations in localized colon cancer","volume":"6","author":"Thomsen","year":"2017","journal-title":"Cancer Med"},{"key":"key20200713185112_b20-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e0108247","DOI":"10.1371\/journal.pone.0108247","article-title":"Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer","volume":"10","author":"Spindler","year":"2015","journal-title":"PLoS One"},{"key":"key20200713185112_b21-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.2119\/molmed.2015.00149","article-title":"Detection and clinical significance of circulating tumor cells in colorectal cancer-20 years of progress","volume":"21","author":"Hardingham","year":"2015","journal-title":"Mol Med"},{"key":"key20200713185112_b22-ijo-53-04-1395","first-page":"1","article-title":"Validation of liquid biopsy: Plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer","volume":"9","author":"Veldore","year":"2018","journal-title":"Lung Cancer (Auckl)"},{"key":"key20200713185112_b23-ijo-53-04-1395","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0035-x","article-title":"Clinical utility of circulating non-coding RNAs - an update","author":"Anfossi","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"key20200713185112_b24-ijo-53-04-1395","first-page":"1461","article-title":"Extracellular MicroRNA in liquid biopsy: Applicability in cancer diagnosis and prevention","volume":"6","author":"Izzotti","year":"2016","journal-title":"Am J Cancer Res"},{"key":"key20200713185112_b25-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell Stem Cell"},{"key":"key20200713185112_b26-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1373\/clinchem.2013.206359","article-title":"Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients","volume":"59","author":"Taly","year":"2013","journal-title":"Clin Chem"},{"key":"key20200713185112_b27-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00268-004-7366-8","article-title":"Molecular detection of APC, K-ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers","volume":"28","author":"Wang","year":"2004","journal-title":"World J Surg"},{"key":"key20200713185112_b28-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e1004271","DOI":"10.1371\/journal.pgen.1004271","article-title":"Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing","volume":"10","author":"Mohan","year":"2014","journal-title":"PLoS Genet"},{"key":"key20200713185112_b29-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tranon.2018.02.007","article-title":"Comparison of the SuperARMS and Droplet Digital PCR for detecting EGFR mutation in ctDNA from NSCLC patients","volume":"11","author":"Feng","year":"2018","journal-title":"Transl Oncol"},{"key":"key20200713185112_b30-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat Med"},{"key":"key20200713185112_b31-ijo-53-04-1395","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/1078-0432.1219.11.3","article-title":"Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer","volume":"11","author":"Fujiwara","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20200713185112_b32-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/bjc.2015.225","article-title":"Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease","volume":"113","author":"Szpechcinski","year":"2015","journal-title":"Br J Cancer"},{"key":"key20200713185112_b33-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1093\/nar\/gkv795","article-title":"DREAMing: A simple and ultrasensitive method for assessing intratumor epigenetic heterogeneity directly from liquid biopsies","volume":"43","author":"Pisanic","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key20200713185112_b34-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","article-title":"Analysis of circulating tumor DNA to monitor metastatic breast cancer","volume":"368","author":"Dawson","year":"2013","journal-title":"N Engl J Med"},{"key":"key20200713185112_b35-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"key":"key20200713185112_b36-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10549-017-4190-z","article-title":"Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing","volume":"163","author":"Yanagawa","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"key20200713185112_b37-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1158\/1078-0432.CCR-17-1181","article-title":"ESR1 Methylation: A liquid biopsy-based epigenetic assay for the follow-up of patients with metastatic breast cancer receiving endocrine treatment","volume":"24","author":"Mastoraki","year":"2018","journal-title":"Clin Cancer Res"},{"key":"key20200713185112_b38-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"42008","DOI":"10.18632\/oncotarget.5788","article-title":"Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma","volume":"6","author":"Gray","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713185112_b39-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12967-016-0852-6","article-title":"Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF\/MEK inhibitors","volume":"14","author":"Schreuer","year":"2016","journal-title":"J Transl Med"},{"key":"key20200713185112_b40-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1158\/1078-0432.CCR-12-0309","article-title":"Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma","volume":"18","author":"Madic","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20200713185112_b41-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e0145754","DOI":"10.1371\/journal.pone.0145754","article-title":"Personalized Circulating Tumor DNA Biomarkers dynamically predict treatment response and survival in gynecologic cancers","volume":"10","author":"Pereira","year":"2015","journal-title":"PLoS One"},{"key":"key20200713185112_b42-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"136ra68","DOI":"10.1126\/scitranslmed.3003726","article-title":"Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA","volume":"4","author":"Forshew","year":"2012","journal-title":"Sci Transl Med"},{"key":"key20200713185112_b43-ijo-53-04-1395","first-page":"3467","article-title":"Cell-free DNA level as a prognostic biomarker for epithelial ovarian cancer","volume":"32","author":"No","year":"2012","journal-title":"Anticancer Res"},{"key":"key20200713185112_b44-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"21429","DOI":"10.18632\/oncotarget.15249","article-title":"RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA","volume":"8","author":"Giannopoulou","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185112_b45-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1373\/clinchem.2012.196014","article-title":"Cancer genome scanning in plasma: Detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing","volume":"59","author":"Chan","year":"2013","journal-title":"Clin Chem"},{"key":"key20200713185112_b46-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s12072-013-9437-0","article-title":"Methylation profiling of serum DNA from hepatocellular carcinoma patients using an Infinium Human Methylation 450 BeadChip","volume":"7","author":"Zhang","year":"2013","journal-title":"Hepatol Int"},{"key":"key20200713185112_b47-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00432-005-0049-5","article-title":"The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma","volume":"132","author":"Ren","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20200713185112_b48-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.7150\/jca.15823","article-title":"Detecting circulating tumor DNA in hepatocellular carcinoma patients using Droplet Digital PCR is feasible and reflects intratumoral heterogeneity","volume":"7","author":"Huang","year":"2016","journal-title":"J Cancer"},{"key":"key20200713185112_b49-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/gm434","article-title":"Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing","volume":"5","author":"Heitzer","year":"2013","journal-title":"Genome Med"},{"key":"key20200713185112_b50-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/2159-8290.CD-17-0937","article-title":"Circulating tumor DNA genomics correlate with resistance to Abiraterone and Enzalutamide in prostate cancer","volume":"8","author":"Annala","year":"2018","journal-title":"Cancer Discov"},{"key":"key20200713185112_b51-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s13277-012-0634-6","article-title":"Characterization of cell-free circulating DNA in plasma in patients with prostate cancer","volume":"34","author":"Delgado","year":"2013","journal-title":"Tumour Biol"},{"key":"key20200713185112_b52-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clgc.2017.12.008","article-title":"Prognostic and therapeutic implications of circulating androgen receptor gene copy number in prostate cancer patients using Droplet Digital polymerase chain reaction","volume":"16","author":"Buelens","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"key20200713185112_b53-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1111\/j.1440-1746.2010.06417.x","article-title":"Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression","volume":"25","author":"Pu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"key20200713185112_b54-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s13277-013-0753-8","article-title":"Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer","volume":"34","author":"Liu","year":"2013","journal-title":"Tumour Biol"},{"key":"key20200713185112_b55-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e17745","DOI":"10.1371\/journal.pone.0017745","article-title":"Circulating plasma miR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis","volume":"6","author":"Cheng","year":"2011","journal-title":"PLoS One"},{"key":"key20200713185112_b56-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s13277-014-2760-9","article-title":"Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer","volume":"36","author":"Lv","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200713185112_b57-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00384-017-2814-8","article-title":"Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer","volume":"32","author":"Krawczyk","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"key20200713185112_b58-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ijc.25007","article-title":"Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer","volume":"127","author":"Huang","year":"2010","journal-title":"Int J Cancer"},{"key":"key20200713185112_b59-ijo-53-04-1395","doi-asserted-by":"crossref","first-page":"76250","DOI":"10.18632\/oncotarget.12841","article-title":"Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713185112_b60-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e92921","DOI":"10.1371\/journal.pone.0092921","article-title":"Circulating exosomal microRNAs as biomarkers of colon cancer","volume":"9","author":"Ogata-Kawata","year":"2014","journal-title":"PLoS One"},{"key":"key20200713185112_b61-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gut.2008.167817","article-title":"Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening","volume":"58","author":"Ng","year":"2009","journal-title":"Gut"},{"key":"key20200713185112_b62-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/bjc.2014.489","article-title":"Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma","volume":"111","author":"Zheng","year":"2014","journal-title":"Br J Cancer"},{"key":"key20200713185112_b63-ijo-53-04-1395","first-page":"9291","article-title":"Decreased plasma let-7c and miR-152 as noninvasive biomarker for non-small-cell lung cancer","volume":"8","author":"Dou","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20200713185112_b64-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.gene.2013.10.024","article-title":"Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer","volume":"534","author":"Yu","year":"2014","journal-title":"Gene"},{"key":"key20200713185112_b65-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00432-013-1555-5","article-title":"Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer","volume":"140","author":"Li","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20200713185112_b66-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12931-014-0149-3","article-title":"Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer","volume":"15","author":"Geng","year":"2014","journal-title":"Respir Res"},{"key":"key20200713185112_b67-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1200\/JCO.2009.24.9342","article-title":"Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer","volume":"28","author":"Hu","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20200713185112_b68-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1002\/ijc.25289","article-title":"Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers","volume":"127","author":"Yu","year":"2010","journal-title":"Int J Cancer"},{"key":"key20200713185112_b69-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12032-011-9923-y","article-title":"High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer","volume":"29","author":"Liu","year":"2012","journal-title":"Med Oncol"},{"key":"key20200713185112_b70-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"111902","DOI":"10.18632\/oncotarget.22950","article-title":"A plasma miRNA signature for lung cancer early detection","volume":"8","author":"Leng","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185112_b71-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1373\/clinchem.2010.151845","article-title":"Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer","volume":"57","author":"Asaga","year":"2011","journal-title":"Clin Chem"},{"key":"key20200713185112_b72-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1756-0500-2-89","article-title":"Circulating microRNAs in breast cancer and healthy subjects","volume":"2","author":"Zhu","year":"2009","journal-title":"BMC Res Notes"},{"key":"key20200713185112_b73-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/SLA.0b013e3181cc939f","article-title":"Circulating microRNAs as novel minimally invasive biomarkers for breast cancer","volume":"251","author":"Heneghan","year":"2010","journal-title":"Ann Surg"},{"key":"key20200713185112_b74-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"13387","DOI":"10.18632\/oncotarget.3874","article-title":"Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients","volume":"6","author":"St\u00fcckrath","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713185112_b75-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40364-015-0037-0","article-title":"Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR","volume":"3","author":"Mangolini","year":"2015","journal-title":"Biomark Res"},{"key":"key20200713185112_b76-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1158\/1078-0432.CCR-14-2011","article-title":"A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients","volume":"21","author":"Kleivi Sahlberg","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key20200713185112_b77-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"12110","DOI":"10.18632\/oncotarget.3661","article-title":"Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer","volume":"6","author":"Margue","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713185112_b78-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/cncr.28981","article-title":"Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients","volume":"121","author":"Fleming","year":"2015","journal-title":"Cancer"},{"key":"key20200713185112_b79-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.18632\/oncotarget.3142","article-title":"A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients","volume":"6","author":"Ono","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713185112_b80-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ebiom.2015.05.011","article-title":"The prognostic and predictive value of melanoma-related microRNAs using tissue and serum: A microRNA expression analysis","volume":"2","author":"Stark","year":"2015","journal-title":"EBioMedicine"},{"key":"key20200713185112_b81-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1479-5876-10-155","article-title":"Serum microRNAs as biomarkers for recurrence in melanoma","volume":"10","author":"Friedman","year":"2012","journal-title":"J Transl Med"},{"key":"key20200713185112_b82-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jdermsci.2010.12.010","article-title":"The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker","volume":"61","author":"Kanemaru","year":"2011","journal-title":"J Dermatol Sci"},{"key":"key20200713185112_b83-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1010428317701646","DOI":"10.1177\/1010428317701646","article-title":"Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma","volume":"39","author":"Fogli","year":"2017","journal-title":"Tumour Biol"},{"key":"key20200713185112_b84-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"89811","DOI":"10.18632\/oncotarget.20688","article-title":"A combination of circulating miRNAs for the early detection of ovarian cancer","volume":"8","author":"Yokoi","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185112_b85-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.canlet.2016.12.017","article-title":"Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts","volume":"388","author":"Todeschini","year":"2017","journal-title":"Cancer Lett"},{"key":"key20200713185112_b86-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s12094-015-1303-1","article-title":"Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features","volume":"17","author":"Zuberi","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"key20200713185112_b87-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1007\/s13277-015-3191-y","article-title":"Serum microRNA-145 as a novel biomarker in human ovarian cancer","volume":"36","author":"Liang","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200713185112_b88-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1007\/s13277-015-3138-3","article-title":"MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer","volume":"36","author":"Gao","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200713185112_b89-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3892\/or.2015.3937","article-title":"Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma","volume":"33","author":"Zhou","year":"2015","journal-title":"Oncol Rep"},{"key":"key20200713185112_b90-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ygyno.2017.11.005","article-title":"Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer","volume":"148","author":"Shah","year":"2018","journal-title":"Gynecol Oncol"},{"key":"key20200713185112_b91-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/CS20100297","article-title":"Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies","volume":"120","author":"Gui","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"key20200713185112_b92-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3109\/13547500903150771","article-title":"MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma","volume":"14","author":"Yamamoto","year":"2009","journal-title":"Biomarkers"},{"key":"key20200713185112_b93-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mc.20712","article-title":"Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis","volume":"50","author":"Xu","year":"2011","journal-title":"Mol Carcinog"},{"key":"key20200713185112_b94-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1200\/JCO.2011.38.2697","article-title":"Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma","volume":"29","author":"Zhou","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20200713185112_b95-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.1158\/0008-5472.CAN-10-1001","article-title":"Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"key":"key20200713185112_b96-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"15350","DOI":"10.18632\/oncotarget.24601","article-title":"Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma","volume":"9","author":"Moshiri","year":"2018","journal-title":"Oncotarget"},{"key":"key20200713185112_b97-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/dna.2014.2663","article-title":"Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer","volume":"34","author":"Kachakova","year":"2015","journal-title":"DNA Cell Biol"},{"key":"key20200713185112_b98-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/bjc.2011.595","article-title":"Changes in circulating microRNA levels associated with prostate cancer","volume":"106","author":"Bryant","year":"2012","journal-title":"Br J Cancer"},{"key":"key20200713185112_b99-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1038\/bjc.2014.181","article-title":"Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer","volume":"110","author":"Lin","year":"2014","journal-title":"Br J Cancer"},{"key":"key20200713185112_b100-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"12613","DOI":"10.1007\/s13277-014-2584-7","article-title":"Circulating miRNAs 21 and 221 as biomarkers for early diagnosis of prostate cancer","volume":"35","author":"Kotb","year":"2014","journal-title":"Tumour Biol"},{"key":"key20200713185112_b101-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e76994","DOI":"10.1371\/journal.pone.0076994","article-title":"MicroRNA profiling in prostate cancer-the diagnostic potential of urinary miR-205 and miR-214","volume":"8","author":"Srivastava","year":"2013","journal-title":"PLoS One"},{"key":"key20200713185112_b102-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"824","DOI":"10.18632\/oncotarget.1776","article-title":"Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients","volume":"5","author":"Singh","year":"2014","journal-title":"Oncotarget"},{"key":"key20200713185112_b103-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/carcin\/bgy025","article-title":"A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer","volume":"39","author":"Farran","year":"2018","journal-title":"Carcinogenesis"},{"key":"key20200713185112_b104-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.2147\/OTT.S119027","article-title":"Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: Evaluation of potential diagnostic and prognostic role","volume":"9","author":"Cochetti","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20200713185112_b105-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1373\/clinchem.2016.257469","article-title":"Detection of KRAS mutations in circulating tumor DNA by digital PCR in early stages of pancreatic cancer","volume":"62","author":"Brychta","year":"2016","journal-title":"Clin Chem"},{"key":"key20200713185112_b106-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/cncr.29364","article-title":"Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer","volume":"121","author":"Kinugasa","year":"2015","journal-title":"Cancer"},{"key":"key20200713185112_b107-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.ejca.2012.03.007","article-title":"Lung cancer in never smokers-a review","volume":"48","author":"Couraud","year":"2012","journal-title":"Eur J Cancer"},{"key":"key20200713185112_b108-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/bjc.2015.168","article-title":"miR-320e is a novel prognostic biomarker in colorectal cancer","volume":"113","author":"Perez-Carbonell","year":"2015","journal-title":"Br J Cancer"},{"key":"key20200713185112_b109-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1158\/0008-5472.CAN-08-0101","article-title":"Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia","volume":"68","author":"Case","year":"2008","journal-title":"Cancer Res"},{"key":"key20200713185112_b110-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1586\/14737159.2015.1094379","article-title":"Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer","volume":"15","author":"Lin","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"key20200713185112_b111-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/ERC-15-0369","article-title":"Methylated circulating tumor DNA in blood: Power in cancer prognosis and response","volume":"23","author":"Warton","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"key20200713185112_b112-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"E125","DOI":"10.3390\/genes7120125","article-title":"Evaluation of methylation biomarkers for detection of crculating tumor DNA and application to colorectal cancer","volume":"7","author":"Mitchell","year":"2016","journal-title":"Genes (Basel)"},{"key":"key20200713185112_b113-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/0976-500X.99416","article-title":"MicroRNAs as newer therapeutic targets: A big hope from a tiny player","volume":"3","author":"Ghelani","year":"2012","journal-title":"J Pharmacol Pharmacother"},{"key":"key20200713185112_b114-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat Rev Genet"},{"key":"key20200713185112_b115-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrg3471","article-title":"Adult-specific functions of animal microRNAs","volume":"14","author":"Sun","year":"2013","journal-title":"Nat Rev Genet"},{"key":"key20200713185112_b116-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ceb.2009.04.009","article-title":"Mechanisms of miRNAmediated post-transcriptional regulation in animal cells","volume":"21","author":"Chekulaeva","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"key20200713185112_b117-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"key20200713185112_b118-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fgene.2015.00186","article-title":"Genetic variants in microRNA genes: Impact on microRNA expression, function, and disease","volume":"6","author":"Cammaerts","year":"2015","journal-title":"Front Genet"},{"key":"key20200713185112_b119-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1186\/gb-2014-15-4-r57","article-title":"Evidence for the biogenesis of more than 1,000 novel human microRNAs","volume":"15","author":"Friedl\u00e4nder","year":"2014","journal-title":"Genome Biol"},{"key":"key20200713185112_b120-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gku1156","article-title":"YM500v2: A small RNA sequencing (smRNA-seq) database for human cancer miRNome research","volume":"43","author":"Cheng","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key20200713185112_b121-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"E1106","DOI":"10.1073\/pnas.1420955112","article-title":"Analysis of 13 cell types reveals evidence for the expression of numerous novel primate-and tissue-specific microRNAs","volume":"112","author":"Londin","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185112_b122-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gkj112","article-title":"miRBase: MicroRNA sequences, targets and gene nomenclature","volume":"34","author":"Griffiths-Jones","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"key20200713185112_b123-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.bcp.2011.08.007","article-title":"Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development","volume":"82","author":"Gambari","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key20200713185112_b124-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3892\/ijo.2013.2059","article-title":"From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment","volume":"43","author":"Piva","year":"2013","journal-title":"Int J Oncol"},{"key":"key20200713185112_b125-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2016.3503","article-title":"Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: \u039dew trends in the development of miRNA therapeutic strategies in oncology","volume":"49","author":"Gambari","year":"2016","journal-title":"Int J Oncol"},{"key":"key20200713185112_b126-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1002\/smll.201500540","article-title":"Combined Delivery of temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cells","volume":"11","author":"Bertucci","year":"2015","journal-title":"Small"},{"key":"key20200713185112_b127-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1038\/s41598-018-22142-x","article-title":"Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery","volume":"8","author":"Gheinani","year":"2018","journal-title":"Sci Rep"},{"key":"key20200713185112_b128-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e0179451","DOI":"10.1371\/journal.pone.0179451","article-title":"Supplementation with small-extracellular vesicles from ovarian follicular fluid during in vitro production modulates bovine embryo development","volume":"12","author":"da Silveira","year":"2017","journal-title":"PLoS One"},{"key":"key20200713185112_b129-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/1878-0261.12025","article-title":"Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer","volume":"11","author":"Halvorsen","year":"2017","journal-title":"Mol Oncol"},{"key":"key20200713185112_b130-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12094-016-1599-5","article-title":"Exosomal microRNAs in liquid biopsies: Future biomarkers for prostate cancer","volume":"19","author":"Valentino","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"key20200713185112_b131-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1167\/iovs.15-17828","article-title":"MicroRNA profiling in aqueous humor of individual human eyes by next-generation sequencing","volume":"57","author":"Wecker","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20200713185112_b132-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00018-014-1811-0","article-title":"Interactions between cancer cells and normal cells via miRNAs in extracellular vesicles","volume":"72","author":"Nishida-Aoki","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"key20200713185112_b133-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PPO.0b013e318258b78f","article-title":"The role of microRNAs in colorectal cancer","volume":"18","author":"Schetter","year":"2012","journal-title":"Cancer J"},{"key":"key20200713185112_b134-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer: Molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N Engl J Med"},{"key":"key20200713185112_b135-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"7255","DOI":"10.1007\/s00216-016-9806-3","article-title":"Biosensors for liquid biopsy: Circulating nucleic acids to diagnose and treat cancer","volume":"408","author":"Bellassai","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"key20200713185112_b136-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nchem.2270","article-title":"An electrochemical clamp assay for direct, rapid analysis of circulating nucleic acids in serum","volume":"7","author":"Das","year":"2015","journal-title":"Nat Chem"},{"key":"key20200713185112_b137-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1021\/ac202578x","article-title":"Evaluation of a Droplet Digital polymerase chain reaction format for DNA copy number quantification","volume":"84","author":"Pinheiro","year":"2012","journal-title":"Anal Chem"},{"key":"key20200713185112_b138-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4939-7778-9_7","article-title":"Biomarkers in cerebrospinal fluid: Analysis of cell-free circulating mitochondrial DNA by digital PCR","volume":"1768","author":"Podlesniy","year":"2018","journal-title":"Methods Mol Biol"},{"key":"key20200713185112_b139-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"18296","DOI":"10.18632\/oncotarget.24817","article-title":"Proof of concept: Prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR","volume":"9","author":"Macagno","year":"2018","journal-title":"Oncotarget"},{"key":"key20200713185112_b140-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1002\/cncr.31331","article-title":"Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels","volume":"124","author":"DiNardo","year":"2018","journal-title":"Cancer"},{"key":"key20200713185112_b141-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12254-017-0361-1","article-title":"Next generation sequencing: Clinical applications in solid tumours","volume":"10","author":"M\u00fcllauer","year":"2017","journal-title":"Memo"},{"key":"key20200713185112_b142-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bios.2016.11.045","article-title":"Integration of isothermal amplification methods in microfluidic devices: Recent advances","volume":"90","author":"Giuffrida","year":"2017","journal-title":"Biosens Bioelectron"},{"key":"key20200713185112_b143-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s00216-014-8405-4","article-title":"Isothermal circular-strand-displacement polymerization of DNA and microRNA in digital microfluidic devices","volume":"407","author":"Giuffrida","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"key20200713185112_b144-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2004.06.043","article-title":"Detection of circulating tumor cells and of tumor DNA in plasma during tumor progression in rats","volume":"217","author":"Garcia-Olmo","year":"2005","journal-title":"Cancer Lett"},{"key":"key20200713185112_b145-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.1158\/0008-5472.CAN-07-0605","article-title":"Serial assessment of human tumor burdens in mice by the analysis of circulating DNA","volume":"67","author":"Rago","year":"2007","journal-title":"Cancer Res"},{"key":"key20200713185112_b146-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.1093\/nar\/gkq421","article-title":"Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts","volume":"38","author":"Thierry","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"key20200713185112_b147-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci US A"},{"key":"key20200713185112_b148-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/ijc.26405","article-title":"Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease","volume":"131","author":"Selth","year":"2012","journal-title":"Int J Cancer"},{"key":"key20200713185112_b149-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e50459","DOI":"10.1371\/journal.pone.0050459","article-title":"Relationship between circulating and tissue microRNAs in a murine model of breast cancer","volume":"7","author":"Waters","year":"2012","journal-title":"PLoS One"},{"key":"key20200713185112_b150-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.molonc.2015.10.004","article-title":"Development of a circulating miRNA assay to monitor tumor burden: From mouse to man","volume":"10","author":"Greystoke","year":"2016","journal-title":"Mol Oncol"},{"key":"key20200713185112_b151-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13046-018-0788-1","article-title":"Liquid biopsy in mice bearing colorectal carcinoma xenografts: Gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)","volume":"37","author":"Gasparello","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"key20200713185112_b152-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/CCO.0000000000000343","article-title":"Liquid biopsy for early detection of lung cancer","volume":"29","author":"Hofman","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"key20200713185112_b153-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"517","DOI":"10.21037\/tlcr.2016.10.15","article-title":"Liquid biopsy in early stage lung cancer","volume":"5","author":"P\u00e9rez-Ram\u00edrez","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"key20200713185112_b154-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1002\/ijc.30565","article-title":"Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients","volume":"140","author":"Bedin","year":"2017","journal-title":"Int J Cancer"},{"key":"key20200713185112_b155-ijo-53-04-1395","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/annonc\/mdx004","article-title":"High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients","volume":"28","author":"Allenson","year":"2017","journal-title":"Ann Oncol"},{"key":"key20200713185112_b156-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/cas.12880","article-title":"Novel combination of serum microRNA for detecting breast cancer in the early stage","volume":"107","author":"Shimomura","year":"2016","journal-title":"Cancer Sci"},{"key":"key20200713185112_b157-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1373\/clinchem.2016.270207","article-title":"Free-circulating methylated DNA in blood for diagnosis, staging, prognosis, and monitoring of head and neck squamous cell carcinoma patients: An observational prospective cohort study","volume":"63","author":"Schr\u00f6ck","year":"2017","journal-title":"Clin Chem"},{"key":"key20200713185112_b158-ijo-53-04-1395","doi-asserted-by":"crossref","first-page":"48507","DOI":"10.18632\/oncotarget.17397","article-title":"Implementing liquid biopsies into clinical decision making for cancer immunotherapy","volume":"8","author":"Quandt","year":"2018","journal-title":"Oncotarget"},{"key":"key20200713185112_b159-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1158\/2159-8290.CD-17-0261","article-title":"Circulating cell-free DNA to quide prostate cancer treatment with PARP inhibition","volume":"7","author":"Goodall","year":"2017","journal-title":"Cancer Discov"},{"key":"key20200713185112_b160-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2217\/fon-2016-0427","article-title":"Circulating tumor cells and DNA for real-time EGFR detection and monitoring of non-small-cell lung cancer","volume":"13","author":"He","year":"2017","journal-title":"Future Oncol"},{"key":"key20200713185112_b161-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1039\/c2lc40100b","article-title":"Isothermal nucleic acid amplification technologies for point-of-care diagnostics: A critical review","volume":"12","author":"Craw","year":"2012","journal-title":"Lab Chip"},{"key":"key20200713185112_b162-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4155\/bio.10.172","article-title":"Isothermal DNA amplification in bioanalysis: strategies and applications","volume":"3","author":"Kim","year":"2011","journal-title":"Bioanalysis"},{"key":"key20200713185112_b163-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1093\/nar\/gkn1024","article-title":"Sensitive fluorescence detection of nucleic acids based on isothermal circular strand-displacement polymerization reaction","volume":"37","author":"Guo","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"key20200713185112_b164-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"8711","DOI":"10.1021\/ac2021932","article-title":"Direct detection of point mutations in nonamplified human genomic DNA","volume":"83","author":"D'Agata","year":"2011","journal-title":"Anal Chem"},{"key":"key20200713185112_b165-ijo-53-04-1395","unstructured":"AlbitarMHematopoietic cell phenotyping using circulating cell-free markersUS Patent9,255,926 B2Filed August 17, 2006, issued February 9, 2016"},{"key":"key20200713185112_b166-ijo-53-04-1395","unstructured":"ThierryAMolinaFAnalytical methods for cell free nucleic acids and applicationsEuropean Patent2,426,217A1Filed September 9, 2010; issued March 7, 2012"},{"key":"key20200713185112_b167-ijo-53-04-1395","unstructured":"PlaticaOMethod of mutation detection in blood cell-free DNA using primer extension (PE) and PCRUS Patent9,062,350 B2Filed March 11, 2012; issued June 23, 2015"},{"key":"key20200713185112_b168-ijo-53-04-1395","unstructured":"HoonDSBTabackBDNA markers for management of cancerUS Patent7,718,364 B2Filed March 25, 2004; issued May 18, 2010"},{"key":"key20200713185112_b169-ijo-53-04-1395","unstructured":"Cortese Rand Petronis A: Method for analysis of DNA methylation profiles of cell-free circulating DNA in bodily fluidsEuropean Patent2,483,426 A4Filed October 1, 2010; issued April 4, 2013"},{"key":"key20200713185112_b170-ijo-53-04-1395","unstructured":"SchutzEBeckJUrnovitzHColorectal cancer associated circulating nucleic acid biomarkersUS Patent2014\/0303008A1Filed October 19, 2012; issued October 9, 2014"},{"key":"key20200713185112_b171-ijo-53-04-1395","unstructured":"MurtazaMContente-CuomoTQuality assessment of circulating cell-free DNA using multiplexed droplet digital PCRWO Patent2016\/168844A1Filed April 17, 2015; issued October 10, 2016"},{"key":"key20200713185112_b172-ijo-53-04-1395","unstructured":"HoonDSBUmetaniNSunamiEUse of free circulating DNA for diagnosis, prognosis, and treatment of cancerWO Patent2006\/128192 A2Filed May 27, 2005; issued November 30, 2006"},{"key":"key20200713185112_b173-ijo-53-04-1395","unstructured":"RaymondCKLimLPArmourCDMethods for quantitative genetic analysis of cell free DNAUS Patent2016\/0053301 A1Filed August 22, 2014; issued February 25, 2016"},{"key":"key20200713185112_b174-ijo-53-04-1395","unstructured":"AmbrosVLeeRFuscoAPIsolating Circulating microRNA (miRNA)US Patent9,896,683 B2Filed July 29, 2015; issued February 20, 2018"},{"key":"key20200713185112_b175-ijo-53-04-1395","unstructured":"TaylorDDGercel-TaylorCCancer-derived microvesicle-associated microrna as a diagnostic markerUS Patent8,216,784 B2Filed July 25, 2008; issued July 10, 2012"},{"key":"key20200713185112_b176-ijo-53-04-1395","unstructured":"TaylorDDGercel-TaylorCExosome-associated microRNA as a diagnostic markerEuropean Patent2,806,273 B1Filed August 12, 2013; issued December 5, 2013"},{"key":"key20200713185112_b177-ijo-53-04-1395","unstructured":"CroceCMCalinGAVoliniaSMethods for Diagnosing Pancreatic Cancer Using MicroRNAsUS Patent2013\/0324589 A1Filed August 12, 2013; issued December 5, 2013"},{"key":"key20200713185112_b178-ijo-53-04-1395","unstructured":"DitzelHKodahlARCirculating microRNA based cancer biomarkersEuropean Patent3,011,058 A1Filed December 24, 2014; issued April 27, 2016"},{"key":"key20200713185112_b179-ijo-53-04-1395","unstructured":"CroceCMMicroRNA signatures in human ovarian cancerEuropean Patent3,138,926 A3Filed September 8, 2008; issued April 5, 2017"},{"key":"key20200713185112_b180-ijo-53-04-1395","unstructured":"Plasma microRNAs for the detection of early colorectal cancerEuropean Patent2,944,700 B1Filed October 10, 2012; issued October 18, 2017"},{"key":"key20200713185112_b181-ijo-53-04-1395","unstructured":"ZhangCZengKZhangJBaYChenXLiHSerum or plasma microRNA as biomarkers for non-small cell lung cancerUS Patent9,388,470 B2Filed December 14, 2009; issued July 12, 2016"},{"key":"key20200713185112_b182-ijo-53-04-1395","article-title":"Methods for diagnosing breast cancer using MicroRNAs","author":"Croce","journal-title":"US Patent"},{"key":"key20200713185112_b183-ijo-53-04-1395"},{"key":"key20200713185112_b184-ijo-53-04-1395"},{"key":"key20200713185112_b185-ijo-53-04-1395"},{"key":"key20200713185112_b186-ijo-53-04-1395"},{"key":"key20200713185112_b187-ijo-53-04-1395"},{"key":"key20200713185112_b188-ijo-53-04-1395"},{"key":"key20200713185112_b189-ijo-53-04-1395"},{"key":"key20200713185112_b190-ijo-53-04-1395"},{"key":"key20200713185112_b191-ijo-53-04-1395"},{"key":"key20200713185112_b192-ijo-53-04-1395"},{"key":"key20200713185112_b193-ijo-53-04-1395"},{"key":"key20200713185112_b194-ijo-53-04-1395"},{"key":"key20200713185112_b195-ijo-53-04-1395"},{"key":"key20200713185112_b196-ijo-53-04-1395"},{"key":"key20200713185112_b197-ijo-53-04-1395"},{"key":"key20200713185112_b198-ijo-53-04-1395"},{"key":"key20200713185112_b199-ijo-53-04-1395"},{"key":"key20200713185112_b200-ijo-53-04-1395"},{"key":"key20200713185112_b201-ijo-53-04-1395"},{"key":"key20200713185112_b202-ijo-53-04-1395"},{"key":"key20200713185112_b203-ijo-53-04-1395"},{"issue":"11","key":"key20200713185112_b204-ijo-53-04-1395","first-page":"V2","volume":"10","year":"2012","journal-title":"Circulating miRNAs ICORG"},{"key":"key20200713185112_b205-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/j.bios.2010.02.008","article-title":"Ultrasensitive detection of non-amplified genomic DNA by nanoparticle-enhanced surface-plasmon resonance imaging","volume":"25","author":"D'Agata","year":"2010","journal-title":"Biosens Bioelectron"},{"key":"key20200713185112_b206-ijo-53-04-1395","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00216-012-6563-9","article-title":"Surface plasmon resonance imaging for nucleic acid detection","volume":"405","author":"D'Agata","year":"2013","journal-title":"Anal Bioanal Chem"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T19:53:17Z","timestamp":1661716397000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2018.4516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":206,"URL":"https:\/\/doi.org\/10.3892\/ijo.2018.4516","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]}}}